US Stock MarketDetailed Quotes

ADAP Adaptimmune Therapeutics

Watchlist
  • 0.807
  • +0.007+0.90%
Trading Nov 4 15:40 ET
206.39MMarket Cap-2241P/E (TTM)

About Adaptimmune Therapeutics Company

Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.

Company Profile

SymbolADAP
Company NameAdaptimmune Therapeutics
Listing DateMay 6, 2015
Issue Price17.00
Founded2008
CEOMr. Adrian Rawcliffe
MarketNASDAQ
Employees449
Securities TypeDR
ADS Ratio1.0 : 6.0
Fiscal Year Ends12-31
Address60 Jubilee Avenue,Milton Park
CityAbingdon
ProvinceOxfordshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeOX14 4RX
Phone44-1235-430000

Company Executives

  • Name
  • Position
  • Salary
  • James J. Noble
  • Chief Executive Officer and Director
  • --
  • Adrian Rawcliffe
  • Director and Chief Executive Officer
  • 2.77M
  • Gavin Hilary James Wood
  • Chief Financial Officer and Principal Accounting Officer
  • 1.17M
  • Dr. Elliot Norry
  • Chief Medical Officer
  • 1.18M
  • William C. Bertrand, Jr
  • Chief Operating Officer
  • 1.22M
  • Dr. Helen Tayton-Martin, PhD
  • Chief Business and Strategy Officer
  • 1.18M
  • Dr. Joanna Brewer
  • Chief Scientific Officer
  • --
  • Cintia Piccina
  • Chief Commercial Officer
  • --
  • John Lunger
  • Chief Patient Supply Officer
  • --
  • David M. Mott
  • Chairman of the Board
  • 174.83K
  • Lawrence M. Alleva
  • Independent Director
  • 128.80K
  • Dr. Garry E. Menzel, PhD
  • Independent Director
  • 117.29K
  • Dr. Priti Hegde, PhD
  • Independent Director
  • 82.25K
  • Dr. Kristen M. Hege, M.D.
  • Independent Director
  • 72.63K
  • Dr. Andrew R. Allen, M.D.,PhD
  • Independent Director
  • 83.50K
  • Dr. Ali Behbahani, M.B.A.,M.D.
  • Independent Director
  • 111.54K
  • John P. Furey
  • Independent Director
  • 117.25K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data